Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E W Jeffes

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Dermatology|November 13, 2001
Actinic keratosis. Current treatment optionsE W Jeffes, E H Tang
Journal of the American Academy of Dermatology|October 1, 1989
Stimulation of fibroblasts by paraprotein in scleromyxedemaG M White, E W Jeffes
Archives of Dermatology|December 1, 1990
Congenital circumareolar telangiectasias: a uniquely distributed vascular malformationG M White, E W Jeffes
Clinical and Experimental Dermatology|March 1, 1989
Adjuvant therapy of bullous pemphigoid with dapsoneE W Jeffes, A R Ahmed
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1976
Relationship of CIF, LT, and PIF released in vitro by activated human lymphocytes. II. A further functional comparison of LT and PIF activities on HeLa and L-929 target cellsE W Jeffes, G A Granger
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1975
Relationship of cloning inhibition factor, "lymphotoxin" factor, and proliferation inhibition factor release in vitro by mitogen-activated human lymphoctesE W Jeffes, G A Granger
Clinics in Dermatology|October 1, 1983
Therapy of pemphigusE W Jeffes, A R Ahmed
Dermatologic Clinics|October 1, 1995
Methotrexate and other chemotherapeutic agents used to treat psoriasisE W Jeffes, G D Weinstein
Clinics in Dermatology|October 6, 1997
MethotrexateS Said, E W Jeffes, G D Weinstein
Molecular Immunology|March 1, 1979
Release of LT molecules with restricted physical heterogeneity by a continuous human lymphoid cell line in vitroD S Fair, E W Jeffes, G A Granger
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Dermatology|November 13, 2001
Actinic keratosis. Current treatment optionsE W Jeffes, E H Tang
Journal of the American Academy of Dermatology|October 1, 1989
Stimulation of fibroblasts by paraprotein in scleromyxedemaG M White, E W Jeffes
Archives of Dermatology|December 1, 1990
Congenital circumareolar telangiectasias: a uniquely distributed vascular malformationG M White, E W Jeffes
Clinical and Experimental Dermatology|March 1, 1989
Adjuvant therapy of bullous pemphigoid with dapsoneE W Jeffes, A R Ahmed
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1976
Relationship of CIF, LT, and PIF released in vitro by activated human lymphocytes. II. A further functional comparison of LT and PIF activities on HeLa and L-929 target cellsE W Jeffes, G A Granger
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1975
Relationship of cloning inhibition factor, "lymphotoxin" factor, and proliferation inhibition factor release in vitro by mitogen-activated human lymphoctesE W Jeffes, G A Granger
Clinics in Dermatology|October 1, 1983
Therapy of pemphigusE W Jeffes, A R Ahmed
Dermatologic Clinics|October 1, 1995
Methotrexate and other chemotherapeutic agents used to treat psoriasisE W Jeffes, G D Weinstein
Clinics in Dermatology|October 6, 1997
MethotrexateS Said, E W Jeffes, G D Weinstein
Molecular Immunology|March 1, 1979
Release of LT molecules with restricted physical heterogeneity by a continuous human lymphoid cell line in vitroD S Fair, E W Jeffes, G A Granger
Pageof 4